Labshake search
Citations for Peprotech :
1 - 13 of 13 citations for Opioid receptor antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... and ligand for fms-like tyrosine kinase receptor-3 (10ng/ul) (Peprotech), followed by two rounds of spinoculation (2,530rpm ...
-
bioRxiv - Bioengineering 2022Quote: ... 50 ng/mL receptor activator of NFκ-B ligand (RANKL, 310-01, PeproTech) was added to the coculture medium and maintained for the rest of the culture ...
-
bioRxiv - Developmental Biology 2022Quote: ... undifferentiated WT ESCs were seeded at a density of 250.000 cells per well in 6-well plates and treated with 200ng/mL Wnt antagonist Dickkopf 1 (DKK1) (Peprotech) or 10μM iCRT3 [inhibitor of β-catenin–responsive transcription] (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... and 50 ng/ml receptor activator of nuclear factor κB ligand (RANKL, 310-01, PeproTech). Explants were cultured for 20 days in an incubator at 37°C with 5% CO2 and medium was replaced every 2 days in both compartments ...
-
bioRxiv - Neuroscience 2022Quote: ... qNSCs were treated with aNSC media with the addition of 0.5 μg/mL of the BMP-4 antagonist noggin (PeproTech 120-10C) to more reproducibly induce quiescence exit.
-
bioRxiv - Microbiology 2019Quote: ... and 100 to 500 ng/ml of the receptor activator of NF-κB ligand (RANKL; Peprotech). This process was utilized to promote cell differentiation (34 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and ligand for fms-like tyrosine kinase receptor-3 (10ng/ul) (all from Peprotech, Cranbury, New Jersey). OP-puro was immediately added to the medium (20uM final concentration ...
-
bioRxiv - Neuroscience 2021Quote: ... in the presence of 30 ng/mL M-CSF and 100 ng/mL receptor activator of nuclear factor kappa-B ligand (RANKL, PeproTech) (Sousa et al. ...
-
bioRxiv - Bioengineering 2022Quote: ... priming medium was replaced by osteoclast medium (priming medium + 50 ng/ml receptor activator of nuclear factor κB ligand (RANKL, 310-01, PeproTech)) to induce osteoclastic differentiation ...
-
bioRxiv - Cell Biology 2020Quote: ... Adherent cells were then detached with a cell scrapper and seeded at a density of 5 × 104 cells/cm2 in the presence of 30 ng/mL M-CSF and 100 ng/mL receptor activator of nuclear factor kappa-B ligand (RANKL, PeproTech) (Bartell et al. ...
-
bioRxiv - Microbiology 2020Quote: ... which was also combined with 100 or 500 ng/ml of the receptor activator of the NF-κB ligand (RANKL; Peprotech) application to the basolateral media where indicated.
-
bioRxiv - Bioengineering 2023Quote: ... After 2 days the coculture medium was replaced by coculture medium additionally containing 50 ng/mL receptor activator of NFκ-B ligand (RANKL, 310-01, PeproTech). Medium was changed weekly inside the incubator via the self-healing injection ports by removing 3 mL of the total 6 mL and replacing it by 3 mL fresh coculture medium with double the concentration of dexamethasone ...
-
bioRxiv - Bioengineering 2022Quote: ... macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL) were from PeproTech (London, United Kingdom). Bombyx mori L ...